Ceyda Tunakan Dalgıc

6PUBLICATIONS
27CO-AUTHORS
Immunogenetics (incl. genetic immunology)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Toxicology (incl. clinical toxicology)Infant and child healthCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Apr 14, 2026
Low IgM Levels in Adult IEI: Classification Challenges and Clinical Implications.

Reyhan Gumusburun, Kasım Okan, Ersin Akdaglı

|Apr 02, 2026
Safety and Outcomes of Rapid Drug Desensitization to Various Biologic Agents: A Multidisciplinary Experience.

Kutay Kirdok, Elif Ertuna, Umitcan Ates

|Mar 14, 2026
Immediate-Type PPI Hypersensitivity as a Severe Adverse Drug Reaction: Diagnostic Challenges, Cross-Reactivity, and Real-Life Outcomes.

Ragıp Fatih Kural, Ceyda Tunakan Dalgıç, Yusuf Özeke

|Jan 27, 2026
COVID-19 Outcomes and Risk Factors for Hospitalization in Adult Patients With Primary Immunodeficiency.

Meryem Demir, Ceyda Tunakan Dalgic, Gulhan Bogatekin

|Jul 27, 2023
Interdisciplinary Healthcare Team Experience of Carboplatin and Oxaliplatin Desensitizations in a Tertiary Referral University Hospital.

Ceyda Tunakan Dalgic, Asuman Camyar, Nihal Mete Gokmen

Pageof 1